Hemogenyx Approved For And Issued Hu-PHEC Patent In Europe Read More
Hemogenyx Reports Positive Test Results From Cancer Therapy Treatment Read More
Hemogenyx Gets US Patent For Postnatal Hemogenic Endothelial Cells Read More
Hemogenyx Raises GBP648,200 To Continue T Cell Therapy Development Read More
Hemogenyx Shares Jump On Promising Data From Blood Cancer Therapy Read More
Hemogenyx CDX Antibody Treatment Potentially "Life-Saving" Read More
Hemogenyx Inks USD75,000 Research Deal With Undisclosed Global Firm Read More
Hemogenyx Interim Loss Widens But CDX Antibody Work Progresses Read More
LONDON (Alliance News) - Biotechnology company Hemogenyx Pharmaceuticals PLC said on Tuesday it has appointed Marc Feldmann as executive chairman, with effect next will be who Read More